{"id":162505,"date":"2022-06-09T01:55:12","date_gmt":"2022-06-09T05:55:12","guid":{"rendered":"https:\/\/www.immortalitymedicine.tv\/hillevax-reports-first-quarter-2022-financial-results-and-highlights-recent-company-progress\/"},"modified":"2024-08-18T11:45:02","modified_gmt":"2024-08-18T15:45:02","slug":"hillevax-reports-first-quarter-2022-financial-results-and-highlights-recent-company-progress","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/hillevax-reports-first-quarter-2022-financial-results-and-highlights-recent-company-progress.php","title":{"rendered":"HilleVax Reports First Quarter 2022 Financial Results and Highlights Recent Company Progress"},"content":{"rendered":"<p><![CDATA[Initiated Phase 2b Clinical Trial of HIL-214 Vaccine Candidate for the Prevention of Norovirus-Related Acute Gastroenteritis in Infants (NOR-212)]]><\/p>\n<p>See more here:<br \/>\n<a target=\"_blank\" rel=\"nofollow noopener\" href=\"https:\/\/www.globenewswire.com\/news-release\/2022\/06\/08\/2459173\/0\/en\/HilleVax-Reports-First-Quarter-2022-Financial-Results-and-Highlights-Recent-Company-Progress.html?f=22&amp;fvtc=5&amp;fvtv=46634288\" title=\"HilleVax Reports First Quarter 2022 Financial Results and Highlights Recent Company Progress\">HilleVax Reports First Quarter 2022 Financial Results and Highlights Recent Company Progress<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>See more here: HilleVax Reports First Quarter 2022 Financial Results and Highlights Recent Company Progress <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/hillevax-reports-first-quarter-2022-financial-results-and-highlights-recent-company-progress.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":64,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246886],"tags":[],"class_list":["post-162505","post","type-post","status-publish","format-standard","hentry","category-global-news-feed"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/162505"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/64"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=162505"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/162505\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=162505"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=162505"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=162505"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}